Literature DB >> 23334254

Repeated resection of colorectal cancer pulmonary oligometastases: pooled analysis and prognostic assessment.

Samer Salah1, Kazuhiro Watanabe, Joon Suk Park, Alaa Addasi, Ji Won Park, Jon Zabaleta, Francesco Ardissone, Jhingook Kim, Marc Riquet, Kazunori Nojiri, Mara Gisabella, Sun Young Kim, Kuniya Tanaka.   

Abstract

BACKGROUND: Repeated resection of colorectal cancer pulmonary metastasis is associated with long-term survival. Nevertheless, very limited data addressing the best candidates for repeated pulmonary resection is available. PATIENTS AND METHODS: We searched the PubMed database for retrospective studies evaluating lung metastasectomy for metastatic colorectal cancer (CRC). We included studies with available data about repeated pulmonary metastasectomy. Potential prognostic factors were analyzed for possible impact on survival following the second metastasectomy through univariate and multivariate analysis.
RESULTS: Between 1983 and 2008, 944 lung metastasectomies were carried out on 759 patients. Of those, 148 patients had a second metastasectomy. The 5-year survival rate was 52 % for patients who had 1 metastasectomy and 57.9 % from the second metastasectomy for patients who had repeated resection. More than 2 metastatic pulmonary nodules and maximum diameter of largest pulmonary nodule ≥3 cm were the only independent factors associated with inferior survival following repeated pulmonary resection.
CONCLUSIONS: In selected patients with metastatic CRC, repeated pulmonary metastasectomy offers an excellent chance for long-term survival and is associated with a quite low operative mortality. Patients with more than 2 metastatic nodules and a maximum diameter of the largest metastatic lung nodule of ≥3 cm have a significantly inferior survival.

Entities:  

Mesh:

Year:  2013        PMID: 23334254     DOI: 10.1245/s10434-012-2860-y

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  18 in total

Review 1.  Pulmonary metastasectomy: outcomes and issues according to the type of surgical resection.

Authors:  Masahiko Higashiyama; Toshiteru Tokunaga; Tomoyuki Nakagiri; Daisuke Ishida; Hidenori Kuno; Jiro Okami
Journal:  Gen Thorac Cardiovasc Surg       Date:  2015-04-03

2.  Patterns and treatment of recurrence following pulmonary resection for colorectal metastases.

Authors:  Mitsuru Yokota; Akihiro Kobayashi; Shogo Nomura; Yuji Nishizawa; Masaaki Ito; Kanji Nagai; Norio Saito
Journal:  World J Surg       Date:  2015-07       Impact factor: 3.352

3.  Indeterminate pulmonary nodules in colorectal cancer.

Authors:  Eun-Joo Jung; Su-Ran Kim; Chun-Geun Ryu; Jin Hee Paik; Jeong Geun Yi; Dae-Yong Hwang
Journal:  World J Gastroenterol       Date:  2015-03-14       Impact factor: 5.742

Review 4.  Systemic Versus Local Therapies for Colorectal Cancer Pulmonary Metastasis: What to Choose and When?

Authors:  Tony Ibrahim; Lambros Tselikas; Charbel Yazbeck; Joseph Kattan
Journal:  J Gastrointest Cancer       Date:  2016-09

Review 5.  Management of resectable colorectal lung metastases.

Authors:  Sing Yu Moorcraft; George Ladas; Anne Bowcock; Ian Chau
Journal:  Clin Exp Metastasis       Date:  2015-12-10       Impact factor: 5.150

6.  Impact of multimodal therapy in locally recurrent rectal cancer.

Authors:  Y N You; J M Skibber; C-Y Hu; C H Crane; P Das; E S Kopetz; C Eng; B W Feig; M A Rodriguez-Bigas; G J Chang
Journal:  Br J Surg       Date:  2016-03-02       Impact factor: 6.939

Review 7.  Pulmonary metastasectomy for colorectal cancer: how many nodules, how many times?

Authors:  Hong Kwan Kim; Jong Ho Cho; Ho Yun Lee; Jeeyun Lee; Jhingook Kim
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

8.  Patients with colorectal lung oligometastases (L-OMD) treated by dose adapted SABR at diagnosis of oligometastatic disease have better outcomes than patients previously treated for their metastatic disease.

Authors:  Alina Mihai; Yijia Mu; John Armstrong; Mary Dunne; Sushil Beriwal; Luke Rock; Pierre Thirion; Dwight E Heron; Brian Healy Bird; Jennifer Westrup; Conleth Gerard Murphy; M Saiful Huq; Raymond McDermott
Journal:  J Radiosurg SBRT       Date:  2017

9.  Oligometastatic Prostate Cancer: A Comparison between Multimodality Treatment vs. Androgen Deprivation Therapy Alone.

Authors:  Francesco A Mistretta; Stefano Luzzago; Andrea Conti; Elena Verri; Giulia Marvaso; Claudia Collà Ruvolo; Michele Catellani; Ettore Di Trapani; Gabriele Cozzi; Roberto Bianchi; Matteo Ferro; Giovanni Cordima; Antonio Brescia; Maria Cossu Rocca; Vincenzo Mirone; Barbara A Jereczek-Fossa; Franco Nolè; Ottavio de Cobelli; Gennaro Musi
Journal:  Cancers (Basel)       Date:  2022-05-06       Impact factor: 6.639

10.  ctDNA MRD Detection and Personalized Oncogenomic Analysis in Oligometastatic Colorectal Cancer From Plasma and Urine.

Authors:  Bruna Pellini; Nadja Pejovic; Wenjia Feng; Noah Earland; Peter K Harris; Abul Usmani; Jeffrey J Szymanski; Faridi Qaium; Jacqueline Mudd; Marvin Petty; Yuqiu Jiang; Ashla Singh; Christopher A Maher; Lauren E Henke; Haeseong Park; Matthew A Ciorba; Hyun Kim; Matthew G Mutch; Katrina S Pedersen; Benjamin R Tan; William G Hawkins; Ryan C Fields; Aadel A Chaudhuri
Journal:  JCO Precis Oncol       Date:  2021-02-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.